避妊の世界市場：製品種類別・流通チャネル別・男女別・地域別 - 市場分析、シェア、動向、規模、予測 (2020～2026年)
Contraceptive Market, By Product Types, By Distribution Channel, and By Gender, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
|発行||AnalystView Market Insights||商品コード||941364|
|出版日||ページ情報||英文 216 Pages
|避妊の世界市場：製品種類別・流通チャネル別・男女別・地域別 - 市場分析、シェア、動向、規模、予測 (2020～2026年) Contraceptive Market, By Product Types, By Distribution Channel, and By Gender, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026|
|出版日: 2020年05月01日||ページ情報: 英文 216 Pages||
Contraceptive market was valued at USD 32.6 billion by 2019, growing with 5.9% CAGR during the forecast period, 2020-2026
Contraceptive, also known as birth control, is a device or method used to prevent pregnancy. The aim of contraception is to allow a physical relationship without fear of an unwanted pregnancy in minimum cost and maximum comfort. The most effective ways of contraception are sterilization by means of implantable birth control, intrauterine devices (IUDs), and tubal ligation in females and vasectomy in males. Nevertheless, all the methods except sterilization are reversible, almost instantly upon discontinuing them. A sterilization method is a permanent form of birth control which is extremely effective at the regulation of fertility. As per the various research statistics, this method provides contraception for more than 250 million couples across the world.
Also, the demand for hormone-based methods such as injections, vaginal rings, patches, and oral pills is increasing at a constant rate. Other than sterilization and hormone-based therapy, there are various other emergency birth control methods such as spermicides vasectomy available commercially. These methods are used to prevent pregnancy if taken within 72 to 120 hours after unprotected sex. Furthermore, the least effective method used for birth control is physical barriers methods including fertility awareness methods, diaphragms and birth control sponges, and condoms.
The global contraceptive market growth is majorly attributed to the rising prevalence of sexually transmitted diseases (STDs). For example, according to the WHO, over 1 million STDs are acquired every day across the world. This would, in turn, fuel the demand for contraceptive products, driving the industry growth. Few of the other key drivers of the market are growing unmet contraceptive needs in developing economies, rising inclination towards planned delayed pregnancy, and favorable regulatory scenario.
In terms of product types, the global contraceptive market is segmented as injectable, patch, IUD, sub-dermal implants, vaginal ring, spermicides, vasectomy, sponge, diaphragms, condoms, and pills. The condom products are further divided into male and female condoms. IUD i.e. intrauterine device is further sub-segmented as non-hormonal IUD and hormonal IUD.
Among the aforementioned product type Segmentation, the condom segment accounts for the highest value share. These products are widely used to prevent sexually transmitted infections. Furthermore, a growing preference for safe sex practices supports the segment growth to a great extent. In addition, oral contraceptive pills accounted for the significant revenue share in 2019. These products are further divided into Combined Oral Contraceptive (COC), and Progestin-Only Contraceptive (POP). COC product is considered to be the most accepted choice as over the long-acting reversible contraceptives. It includes a combination of a progestogen (progestin) and estrogen (ethinylestradiol). Nevertheless, disadvantages of pills such as migraine, nausea, amplified threat of developing STIs, and irregular bleeding may create hindrance for the segment growth. However, many research studies suggested that regular consumption of these pills reduces the threat of developing endometrial & cervical cancers, minimizes menstrual cramps, and facilitates acne reduction creates a positive impact on the segment.
Distribution Channel Takeaway
Depending upon the distribution channel, the industry is broadly classified as hospital pharmacy, retail pharmacy, clinics, online channel, and public channel. Among the above-mentioned segments, the online channel is anticipated to grow at a substantial rate over the forecast period, attributed to increasing preference for e-Commerce channel. However, due to the presence of a large number of retail pharmacies or drug stores compared to other segments, the retail pharmacy segment accounted for significantly high revenue share.
On the basis of gender, the global contraceptive market is categorized into male and female. Among these, the male segment was accounted for dominating value share in the global market. On the other hand, the female segment is projected to expand at a substantial growth rate; owing to, increasing popularity for the product among the consumers coupled with high improvement in the product. Furthermore, in developing regions such as the Asia Pacific, the need for contraceptive products that are more women-friendly, and provide adequate privacy is increasing continuously which will support the female segment growth to a great extent.
In terms of geography, the global market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Of these, North America accounted for the highest revenue share with the U.S. market is dominating the North America region. Regional growth is majorly attributed to the rising research and development activities coupled with the introduction of new products. For example, in August 2018, U.S. based pharmaceutical company, Therapeutics MD Inc., received U.S. FDA approval of ANNOVERA (EthinylEstradiol Vaginal System/Segesterone Acetate). This contraceptive product is a small, and soft flexible ring that prevents ovulation. Such introductions would, in turn, support the regional growth to a great extent. Further, Europe contraceptives market stands second in terms of value in the global market. Germany's contraceptives market accounts for a relatively high revenue share in the European market than the rest of the countries in the region. A high number of population availing sexual health services is one of the major factors bolstering the European contraceptives market.
On the other side, the Asia Pacific region is projected to grow with a promising growth rate during the study period. High population growth and rapid economic development across prominent countries are the major factors responsible for the growth of the Asia Pacific contraceptive market. India's contraceptives market is anticipated to grow at a substantial growth rate throughout the forecast period, attributed to several government initiatives, growing awareness campaigns, and rising prevalence of STDs.
KEY VENDOR TAKEAWAY
Few of the prominent market players responsible for the market trends include Pfizer, Inc., Allergan, Church & Dwight Co., Inc., Agile Therapeutics, Reckitt Benckiser Plc, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries Ltd., Afaxys, Inc., Mithra Pharmaceuticals, Mayer Laboratories, Inc., The Cooper Companies, Inc., Blairex Laboratories, Inc., Bayer AG, and Merck & Co., Inc.
Key market players of the global contraceptive market are focusing on increasing investments in the research and development activities through collaboration with various entities in the market environment. For instance, in January 2019, Cipla received a final nod for its Medroxyprogesterone injectable used for the prevention of pregnancy from the U.S. health regulator.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
Traders, Distributors, and Suppliers
Government and Regional Agencies
Scope of the Report
The scope of this report covers the market by its major segments, which include as follows:
CONTRACEPTIVE MARKET KEY PLAYERS
Merck & Co., Inc.
Blairex Laboratories, Inc.
The Cooper Companies, Inc.
Mayer Laboratories, Inc.
Teva Pharmaceutical Industries Ltd.
Apothecus Pharmaceutical Corporation
Reckitt Benckiser Plc
Church & Dwight Co., Inc.
CONTRACEPTIVE MARKET BY PRODUCT TYPE
Oral Contraceptive Pill
Combined Oral Contraceptive (COC)
Progestin-Only Contraceptive (POP)
CONTRACEPTIVE MARKET, BY DISTRIBUTION CHANNEL
CONTRACEPTIVE MARKET, BY GENDER
CONTRACEPTIVE MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA